End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.06 EUR | -0.80% | -6.23% | -27.23% |
07-01 | CVS Health Corporation(NYSE:CVS) dropped from Russell 1000 Value-Defensive Index | CI |
07-01 | CVS Health Corporation(NYSE:CVS) dropped from Russell 1000 Defensive Index | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.26 for the current year.
- The stock, which is currently worth 2024 to 0.33 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.23% | 71.18B | - | ||
+18.33% | 85.53B | C+ | ||
+0.99% | 26.76B | C+ | ||
+3.67% | 17.43B | A- | ||
-9.99% | 17.18B | B | ||
+1.86% | 15.65B | A- | ||
+79.98% | 13.71B | C- | ||
+74.41% | 13.27B | C+ | ||
-25.09% | 13.1B | - | - | |
+18.69% | 12.41B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CVS Stock
- 4CVS Stock
- Ratings CVS Health Corporation